Filing Details
- Accession Number:
- 0001209191-11-034177
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-13 07:16:25
- Reporting Period:
- 2011-06-10
- Filing Date:
- 2011-06-13
- Accepted Time:
- 2011-06-13 06:16:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1343266 | W Richard Pascoe | Somaxon Pharmaceuticals, Inc. 3570 Carmel Mountain Road, Suite 100 San Diego CA 92130 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-06-10 | 11,100 | $2.25 | 207,809 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $2.23 to $2.26 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.